Oral Paper Presentation
Annual Scientific Meeting
June Tome, MD
Mayo Clinic
Rochester, MN
Median (range) or n (%) | ||||
Characteristics | All Patients (n = 282) | Bile Acid Testing Performed (n = 90) | No Bile Acid Testing Performed (n = 192) | p-value |
Age | 59 (20-87) | 57 (23-87) | 60 (20-87) | 0.35 |
Sex, female | 249 (88.3%) | 82 (91.1%) | 167 (87.0%) | 0.31 |
Race, white | 276 (97.9%) | 89 (98.9%) | 187 (97.4%) | 0.53 |
Subtype, lymphocytic colitis | 139 (49.3%) | 52 (57.8%) | 87 (45.3%) | 0.06 |
Bowel movements, number | 6 (3-20) | 6 (3-20) | 5 (3-15) | 0.45 |
Body mass index (kg/m2) | 25.4 (16.2-47.0) | 24.5 (16.2-47.0) | 25.7 (16.7-46.4) | 0.21 |
Smoking history | 95 (33.7%) | 37 (41.1%) | 58 (30.2%) | 0.17 |
Cholecystectomy | 69 (24.5%) | 28 (31.1%) | 41 (21.4%) | 0.08 |
Celiac disease | 20 (7.1 %) | 5 (5.6%) | 15 (7.8%) | 0.39 |
Previous medications* | 278 (98.6%) | 88 (97.8%) | 190 (98.9%) | 0.44 |